おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Mythic Therapeutics
company
About
Mythic Therapeutics is a biotechnology company focused on a new generation of groundbreaking cancer therapeutics.
- 11 - 50
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $103M
- Industries
- Biotechnology,Health Care,Life Science,Pharmaceutical,Therapeutics
- Founded date
- Jan 1, 2017
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Mythic Therapeutics is a biotechnology company focused on a new generation of groundbreaking cancer therapeutics. The company is pioneering a powerful protein engineering-focused approach to improving the effectiveness of antibody-drug conjugates (ADCs) and other antibody-based therapeutics. Their technology dramatically increases therapeutic potency without compromising safety, thereby unlocking the full potential of targeted therapies against a broad array of tumor targets.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$103M
Mythic Therapeutics has raised a total of
$103M
in funding over 2 rounds. Their latest funding was raised on
Dec 15, 2021 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 15, 2021 | Series B | $103M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Mythic Therapeutics is funded by 1 investors.
Highside Capital Management
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
